Jaundice following sulfinpyrazone administration
Müller, H.G.
Deutsche Medizinische Wochenschrift 106(35): 1117
1981
ISSN/ISBN: 0012-0472 PMID: 7261936 Document Number: 178510
Document emailed within 1 workday
Related Documents
Mertz, D.P. 1978: The possible mechanism of action of sulfinpyrazone Münchener Medizinische Wochenschrift 120(36): 1139Beilin, L.J. 1978: Sulfinpyrazone after myocardial infarction? Medical Journal of Australia 2(5): 186-188
Jiménez López, A.; Sánchez Martin, S. 1977: Effect of sulfinpyrazone on blood lipids Revista Clinica Espanola 146(1-2): 65-67
Boschetti, C.; Cortellaro, M.; Invernizzi, F.; Massaro, P.; Rigolone, A.; Polli, E. 1985: Treatment with sulfinpyrazone of essential mixed cryoglobulinemia Bollettino dell'Istituto Sieroterapico Milanese 64(1): 55-58
Bolte, H.D. 1980: Sulfinpyrazone (Anturane)--new indication: myocardial infarct? Münchener Medizinische Wochenschrift 122(14): 507-508
Wyse, D.G. 1982: Electrophysiologic effects of low dose intravenous sulfinpyrazone in man Proceedings of the Western Pharmacology Society 25: 289-291
Perez Mijares, R.; Praga Terente, M.; Lopez de Novales, E. 1983: Oliguric acute renal failure after treatment with sulfinpyrazone Clinical Nephrology 19(1): 54
Wilburn, R.L. 1970: Neonatal jaundice secondary to endogenous maternal steroids (breast milk jaundice) Nebraska Medical Journal 55(6): 364-368
Orellana Alcalde, J.M. 1975: A hypothesis regarding the pathogenesis of postoperative transient jaundice (bilirubinostatic jaundice) Acta Gastroenterologica Latinoamericana 6(3): 107-110
Gholson, C.F.; Burton, F.R. 1991: Obstructive jaundice. Nonsurgical options for 'surgical' jaundice Postgraduate Medicine 90(8): 107
Sommariva, D.; Scotti, L.; Baroni, L.; Beggi, P.; Fasoli, A. 1980: Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types Ii and IV La Clinica Terapeutica 92(6): 649-655
Haas, S.; Fritsche, H.M.; Ketterl, R.; Leimgruber, D.; Blümel, G. 1979: Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation Die Medizinische Welt 30(22): 862-867
Prior, C.; Kirchmair, H. 1984: Acute interstitial nephritis and kidney failure requiring dialysis after sulfinpyrazone therapy Acta Medica Austriaca 11(2): 55-59
Rogers, P.H.; Walsh, P.N.; Marder, V.J.; Bosak, G.C.; Lachman, J.W.; Ritchie, W.G.; Oppenheimer, L.; Sherry, S. 1978: Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip Journal of Bone and Joint Surgery. American Volume 60(6): 758-762
Kawabata, A.; Eto, K.; Maegaki, N. 1975: Bedside care of severe neonatal jaundice: nursing of infants with severe jaundice in the intensive care unit Nursing Technique 21(2): 56-63
von Magnus, M.; Kaaber, K. 1998: Guidelines on drug administration and patient self administration of drugs. Sundhedsstyrelsen (Health Administration) Sygeplejersken 98(9): 32-35
Dochy, M. 1987: Double blind comparative study with intrarectal administration of midazolam, intramuscular administration of diazepam and intrarectal administration of diazepam: preliminary results Acta Anaesthesiologica Belgica 38(3 Suppl 1): 45-51
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Hołowiecki, J.; Jarczok, K.; Duraj, M.; Rudzka, E.; Krzemień, S.; Krawczyk, M.; Hołowiecka, B.; Opala, G.; Jagoda, K.; Pawelski, S. 1985: Fractional administration of adriblastin and modified route of ara-C administration for the treatment of acute leukaemia Folia Haematologica 112(5): 689-697
Wetmore, R.W.; Kalt, M.A.; Sybert, J.W.; Hecker, E.T. 1992: Intrathecal administration of morphine followed by patient-controlled intravenous administration for postoperative analgesia Clinical Pharmacy 11(11): 958-961